| Adam Jorgensen, MD | |
|
2800 3rd St, Rapid City, SD 57701 | |
| (605) 341-2000 | |
| (605) 719-3221 |
| Full Name | Adam Jorgensen |
|---|---|
| Gender | Male |
| Speciality | Ophthalmology |
| Experience | 12 Years |
| Location | 2800 3rd St, Rapid City, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366700460 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207WX0009X | Ophthalmology - Glaucoma Specialist | 10322 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Avera St Mary's Hospital | Pierre, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Black Hills Regional Eye Institute Llp | 0547156762 | 12 |
News Archive
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The Dow Chemical Company has awarded UC Santa Barbara up to $15 million to establish a collaborative research initiative that will help shape the future of technology in areas that will benefit society.
European Stroke Organisation (ESO) and Stroke Alliance for Europe (SAFE) initiated the implementation phase of the Stroke Action Plan for Europe 2018-2030, with a virtual meeting of over 80 experts from 52 countries, each involved within their national scientific societies or stroke support organisations
Many people living with the human immunodeficiency virus (HIV) and using antiretroviral therapy (ART) may still have cells sheltering the virus lurking in the cerebrospinal fluid, a new study has found.
› Verified 9 days ago
| Entity Name | Black Hills Regional Eye Institute Llp |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952381881 PECOS PAC ID: 0547156762 Enrollment ID: O20040225000355 |
News Archive
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The Dow Chemical Company has awarded UC Santa Barbara up to $15 million to establish a collaborative research initiative that will help shape the future of technology in areas that will benefit society.
European Stroke Organisation (ESO) and Stroke Alliance for Europe (SAFE) initiated the implementation phase of the Stroke Action Plan for Europe 2018-2030, with a virtual meeting of over 80 experts from 52 countries, each involved within their national scientific societies or stroke support organisations
Many people living with the human immunodeficiency virus (HIV) and using antiretroviral therapy (ART) may still have cells sheltering the virus lurking in the cerebrospinal fluid, a new study has found.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Adam Jorgensen, MD 2800 3rd Street, Rapid City, SD 57701-0000 Ph: (605) 341-2000 | Adam Jorgensen, MD 2800 3rd St, Rapid City, SD 57701 Ph: (605) 341-2000 |
News Archive
Lorus Therapeutics today announced that its wholly owned subsidiary, GeneSense Technologies Inc. (GeneSense), has received notice from the European Patent Office of its intention to grant GeneSense's application for a patent of its novel antisense drug, GTI-2501.
The Dow Chemical Company has awarded UC Santa Barbara up to $15 million to establish a collaborative research initiative that will help shape the future of technology in areas that will benefit society.
European Stroke Organisation (ESO) and Stroke Alliance for Europe (SAFE) initiated the implementation phase of the Stroke Action Plan for Europe 2018-2030, with a virtual meeting of over 80 experts from 52 countries, each involved within their national scientific societies or stroke support organisations
Many people living with the human immunodeficiency virus (HIV) and using antiretroviral therapy (ART) may still have cells sheltering the virus lurking in the cerebrospinal fluid, a new study has found.
› Verified 9 days ago
Scott Eccarius, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 631 Saint Anne St, Suite 103, Rapid City, SD 57701 Phone: 605-343-4120 | |
Dr. Daniel J Hafner, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2800 3rd St, Rapid City, SD 57701 Phone: 605-341-2000 Fax: 605-719-3211 | |
Dr. Ted Harold Fromm, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 240 Minnesota St, Rapid City, SD 57701 Phone: 605-718-5123 | |
Dr. Prema Abraham, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2800 3rd St, Rapid City, SD 57701 Phone: 605-341-2000 Fax: 605-719-3211 | |
Dr. Paul Louis Wright, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 240 Minnesota St, Rapid City, SD 57701 Phone: 605-718-5123 Fax: 605-719-9509 | |
Rebecca Linquist, Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 2820 Mount Rushmore Rd, Rapid City, SD 57701 Phone: 605-342-3280 Fax: 605-721-8458 | |
Robert B Nixon, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 2800 3rd St, Rapid City, SD 57701 Phone: 605-341-2000 Fax: 605-719-3211 |